Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Recruiting 2Active not recruiting 2Not yet recruiting 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Dermatologic 2

Conditions

Prostatic Neoplasms 42Lung Neoplasms 39Leukemia, Myeloid, Acute 38Carcinoma, Non-Small-Cell Lung 33Neoplasm Metastasis 29Breast Neoplasms 28Myelodysplastic Syndromes 21Lymphoma, Large B-Cell, Diffuse 20Leukemia, Lymphocytic, Chronic, B-Cell 19Colorectal Neoplasms 18Pancreatic Neoplasms 17Triple Negative Breast Neoplasms 15Precursor Cell Lymphoblastic Leukemia-Lymphoma 15Multiple Myeloma 15Ovarian Neoplasms 14Glioblastoma 14Carcinoma, Renal Cell 14Squamous Cell Carcinoma of Head and Neck 13Burkitt Lymphoma 13Urinary Bladder Neoplasms 10Mouth Neoplasms 10Melanoma 10Lymphoma, Mantle-Cell 10Endometrial Neoplasms 10Carcinoma, Hepatocellular 10Carcinoma 10Oropharyngeal Neoplasms 9Leukemia, Myelomonocytic, Chronic 9Laryngeal Neoplasms 9Brain Neoplasms 9

Interventions

Nivolumab 3HhAntag691 3Biopsy 3relatlimab 2pembrolizumab 2cemiplimab 2Specimen Handling 2Radiotherapy 2Observation 2Niacinamide 2Magnetic Resonance Spectroscopy 2Ipilimumab 2sonidegib 1prednylidene 1deltacortene 1daromun 1X-Rays 1Watchful Waiting 1Surgical Procedures, Operative 1Sunscreening Agents 1Standard of Care 1Sirolimus 1Second Harmonic Generation Microscopy 1Prednisone 1Predictive Learning Models 1Practice Guidelines as Topic 1Opdualag 1Interleukin-2 1Immunoglobulin G 1Disulfides 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Carcinoma, Basal Cell × Specimen Handling × Clear all
NCT05896839 2026-05-13

Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer

National Cancer Institute (NCI)

Phase 1/2 Recruiting
16 enrolled
Dermatologic

Carcinoma, Basal Cell, Melanoma, Carcinoma, Merkel Cell

NCT05929664 2026-03-24

Cemiplimab Plus Fianlimab for the Treatment of Locally Advanced Head and Neck Basal Cell Carcinoma Before Surgery

Thomas Jefferson University

Phase 2 Recruiting
70 enrolled
Dermatologic

Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡